Does rosuvastatin reduce ischemia/reperfusion injury in humans in-vivo? A randomized, double-blind, placebo-controlled trial.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2009 Results published in Arteriosclerosis Thrombosis and Vascular Biology.
- 22 Sep 2008 Planned end date changed from 1 Aug 2006 to 1 Aug 2007 as reported by ClinicalTrials.gov.